Sergi Clavé

Clinical outcomes of KRAS G12C versus non-G12C mutant NSCLC treated with immunotherapy: a multicentre real-world study

Laura Masfarr, Ana Sofia De Freitas Matos Parreira, N. Castro Unanua, Claudia Miquel et autres

es (code pays fourni par la source)

Gene fusions in non-small cell lung carcinoma (NSCLC): Expert perspectives and practical considerations for routine testing

Beatríz Bellosillo, Javier Freire, Ihab Abdulkader Nallib, Michele Biscuola et autres

es, ps (code pays fourni par la source)

Abstract PS4-04-03: Analytical concordance of NGS-based tests for ESR1 mutation detection in plasma

Alexander Yarunin, A. Martin, Marina Gómez-Rey, A. Baizan et autres

sg, es (code pays fourni par la source)

P2.06.74 Detection of Actionable Biomarkers in Liquid Biopsy From Non-Small Cell Lung Cancer Patients Using NGS-Based Assays

Sergi Clavé, Laura Camacho, Raquel Longarón, Lierni Fernández‐Ibarrondo et autres

es, us (code pays fourni par la source)

EP.06.48 Complementary Role of IHC in ALK Fusion Detection: A Validation Study of NSCLC NGS-Based Screening in Seven Laboratories

Sergi Clavé, Carla Montironi, Glòria Oliveras, M. Varela et autres

es (code pays fourni par la source)

Abstract 726: Comprehensive genomic profiling of cell-free DNA and matched white blood cells improves accuracy of ctDNA molecular response in immunotherapy treated NSCLC

Jennifer Jackson, Pedro Rocha, James White, Andrew Georgiadis et autres

us, es (code pays fourni par la source)

Implementation of NGS Analysis for the Detection of RET Rearrangements in Thyroid Cancer Patients. An Inter-Laboratory Validation of the Method

Marta Sesé, Sergi Clavé, Rosa Somoza, Carles Zafón et autres

Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade

Pedro Rocha, Rafael Bach, Laura Masfarré, Sharia Hernandez et autres

es, us (code pays fourni par la source)

P2.11A.08 Molecular and Immunological Features Associated with Long-Term Benefit in Metastatic NSCLC Patients Undergoing Immune Checkpoint Blockade

P. Rocha, Richard G. Bach, L. Masfarré, S. Hernandez et autres

es, us (code pays fourni par la source)

Abstract 6391: Spatial proteomic profiling unveils pre-existing anti-tumor immunity as a hallmark of exceptional benefit from immunotherapy in NSCLC

Sharia Hernandez, Rafael Bach, Mario Giner, Wei Lu et autres

us, es (code pays fourni par la source)

Abstract 6443: Enhanced detection of ctDNA molecular response for immunotherapy treated non-small cell lung cancer through analyses of cell-free and matched white blood cell DNA

Jennifer Jackson, Pedro Rocha, James R. White, Andrew Georgiadis et autres

us, es (code pays fourni par la source)

55P Differences in response to immune treatment between KRAS G12C and KRAS non-G12C mutated non-small cell lung cancer

L. Masfarre Pinto, A.S. De Freitas Matos-Parreira, N. Castro Unanua, P.F. Simoes da Rocha et autres

es (code pays fourni par la source)